35986841_10216840653711318_1105697261150535680_n
Normal view MARC view ISBD view

Artificial cells : biotechnology, nanomedicine, regenerative medicine, blood substitutes, bioencapsulation, cell/stem cell therapy / Thomas Ming Swi Chang.

By: Chang, Thomas Ming Swi.
Material type: TextTextSeries: Regenerative medicine, artificial cells and nanomedicine ; v. 1. Publisher: Hackensack, N. J. : World Scientific, c2007Edition: 1st ed.Description: xxvi, 455 p. : ill. (some col.) ; 24 cm.ISBN: 9789812705761 (hardcover); 9812705767 (hardcover); 9789812707789 (pbk.); 9812707786 (pbk.).Subject(s): Artificial cells | Blood substitutes | Nanotechnology | Blood Substitutes | Biotechnology | Cells | Nanomedicine | Regenerative MedicineDDC classification: 615.39 Online resources: Table of contents only
Contents:
50th anniversary of artificial cells -- Basic principles -- Oxygen carriers based on nanobiotechnology -- A nanobiotechnologic therapeutic that transports oxygen and remove oxygen radicals: for stroke, hemorrhagic shock and related conditions -- Nanotechnology-based artificial red blood cells (RBC's) -- Use of enzyme artificial cells for genetic enzyme defects that increase systemic substrates to toxic levels -- Enzyme artificial cells in substrate-dependent tumors and activation of prodrug -- Artificial cells for cell encapsulation -- Artificial cells containing hepatocytes and/or stem cells in regenerative medicine -- Hemoperfusion in poisoning, kidney failure, liver failure, and immunology -- Perspectives on the future of artificial cells as suggested by past research.
Tags from this library: No tags from this library for this title. Log in to add tags.
    Average rating: 0.0 (0 votes)
Item type Current location Call number Status Date due Barcode
Books Books Centeral Library
Second Floor - Biotechnology
615.39 C.T.A 2007 (Browse shelf) Available 16176

Includes bibliographical references (p. 377-440).

50th anniversary of artificial cells -- Basic principles -- Oxygen carriers based on nanobiotechnology -- A nanobiotechnologic therapeutic that transports oxygen and remove oxygen radicals: for stroke, hemorrhagic shock and related conditions -- Nanotechnology-based artificial red blood cells (RBC's) -- Use of enzyme artificial cells for genetic enzyme defects that increase systemic substrates to toxic levels -- Enzyme artificial cells in substrate-dependent tumors and activation of prodrug -- Artificial cells for cell encapsulation -- Artificial cells containing hepatocytes and/or stem cells in regenerative medicine -- Hemoperfusion in poisoning, kidney failure, liver failure, and immunology -- Perspectives on the future of artificial cells as suggested by past research.

There are no comments for this item.

Log in to your account to post a comment.